Cutaneous Adverse Reactions to COVID-19 Vaccines: Insights from an Immuno-Dermatological Perspective

(1) Background: Numerous vaccines are under preclinical and clinical development for prevention of severe course and lethal outcome of coronavirus disease 2019 (COVID-19). In light of high efficacy rates and satisfactory safety profiles, some agents have already reached approval and are now distribu...

Full description

Bibliographic Details
Main Authors: Dennis Niebel, Natalija Novak, Jasmin Wilhelmi, Jana Ziob, Dagmar Wilsmann-Theis, Thomas Bieber, Joerg Wenzel, Christine Braegelmann
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Vaccines
Subjects:
Online Access:https://www.mdpi.com/2076-393X/9/9/944